Endogena Therapeutics � Endogena Neurodegeneration

Endogena Therapeutics, founded by Matthias Steger MD PhD, is a clinical-stage biotech company that discovers and develops first-in-class endogenous regenerative medicines to repair and regenerate tissues and organs that have deteriorated due to aging and genetic diseases. Endogena is developing an unspecified endogenous molecule aimed at preventing neurodegeration.